$FREQ

Frequency Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Commercial Services
  • Miscellaneous Commercial Services
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$2.09 ▲4.5%

Extented Hours

VOLUME

159,211

DAY RANGE

2.16 - 2.2922

52 WEEK

1 - 8.42

Join Discuss about FREQ with like-minded investors

SC
@Schmidy23 #droscrew
recently

fuck the high freq guys

135 Replies 12 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

somthing going on in $FREQ just no volume

117 Replies 8 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

$FREQ on watch

61 Replies 13 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

was under water on $FREQ but was only starter size to find it tank later

121 Replies 11 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

$FREQ is a pharmaceutical

49 Replies 8 👍 10 🔥

SO
@soheil.n #StockTraders.NET
recently

$FREQ new $RMO

73 Replies 9 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$FREQ getting interesting

77 Replies 6 👍 12 🔥

SO
@soheil.n #StockTraders.NET
recently

watchlist: ss: $HOFV, $SNMP, $CSCW, $APTO...bounce: $UPST, $FREQ

60 Replies 7 👍 6 🔥

profile
@RedSunCap #droscrew
recently

$FREQ down over 70% on poor drug trial results $BNTC up over 130% on positive drug results $AVEO down 6% on secondary offering Energy stocks hit hard by crude drop

130 Replies 8 👍 10 🔥

PR
@proj8 #StockTraders.NET
recently

$FREQ watching if it bounces

44 Replies 14 👍 12 🔥

profile
@thegiz18 #ivtrades
recently

$FREQ down over 70% on poor drug trial results

100 Replies 12 👍 15 🔥

profile
@truublue #droscrew
recently

I gotta stop by there sometime, I got friends in Redding that I visit semi freq

48 Replies 15 👍 10 🔥

profile
@truublue #droscrew
recently

another little tidbit on the M1: high freq basic computing tasks (retaining and releasing objects) is 54% faster on an M1 emulating an intel chip and 80% faster running code built for its architecture

118 Replies 13 👍 13 🔥

Key Metrics

Market Cap

78.70 M

Beta

1.50

Avg. Volume

489.05 K

Shares Outstanding

34.98 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

Frequency Therapeutics is a leader in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The Company's progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. The Company's lead product candidate, FX-322, is designed to regenerate auditory hair cells to restore hearing function. FX-322 is being evaluated in multiple ongoing clinical studies in patients with sensorineural hearing loss. The Company also is evaluating additional diseases where its PCA approach could create functional tissue, including in a pre-clinical program in multiple sclerosis.

Website:

HQ: ,

Related News